Real-world data shows infliximab safe to use during pregnancy

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2018年 / 1714卷 / 1期
关键词：
D O I：
10.1007/s40278-018-50191-1
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 11
相关论文
共 50 条
  • [31] Real-world experience of metformin use in pregnancy: Observational data from the Northern Territory Diabetes in Pregnancy Clinical Register
    Maple-Brown, Louise J.
    Lindenmayer, Greta
    Barzi, Federica
    Whitbread, Cherie
    Connors, Christine
    Moore, Elizabeth
    Boyle, Jacqueline
    Kirkwood, Marie
    Lee, I-Lynn
    Longmore, Danielle
    van Dokkum, Paula
    Wicks, Mary
    Dowden, Michelle
    Inglis, Chrissie
    Cotter, Margaret
    Kirkham, Renae
    Corpus, Sumaria
    Chitturi, Sridhar
    Thomas, Sujatha
    O'Dea, Kerin
    Zimmet, Paul
    Oats, Jeremy
    McIntyre, Harold D.
    Brown, Alex
    Shaw, Jonathan E.
    Dent, Glynis
    Eades, Sandra
    Stone, Monique
    Harris, Mark
    Dempsey, Karen
    Lynch, Michael
    [J]. JOURNAL OF DIABETES, 2019, 11 (09) : 761 - 770
  • [32] Cost-effectiveness of real-world infliximab use in patients with rheumatoid arthritis in Sweden
    Lekander, Ingrid
    Borgstrom, Fredrik
    Svarvar, Patrick
    Ljung, Tryggve
    Carli, Cheryl
    van Vollenhoven, Ronald F.
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2010, 26 (01) : 54 - 61
  • [33] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
    Richard E. Gliklich
    Michelle B. Leavy
    [J]. Therapeutic Innovation & Regulatory Science, 2020, 54 : 303 - 307
  • [34] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
    Gliklich, Richard E.
    Leavy, Michelle B.
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 303 - 307
  • [35] UNDERSTANDING USE OF REAL-WORLD DATA (RWD) AND REAL-WORLD EVIDENCE (RWE) TO SUPPORT EFFECTIVENESS LABELING CHANGES
    Mercon, K.
    Eckert, J. C.
    Mahendraratnam, N.
    Kroetsch, A. F.
    Wosinska, M.
    McClellan, M.
    [J]. VALUE IN HEALTH, 2020, 23 : S384 - S384
  • [36] Understanding Use of Real-World Data and Real-World Evidence to Support Regulatory Decisions on Medical Product Effectiveness
    Mahendraratnam, Nirosha
    Mercon, Kerra
    Gill, Mira
    Benzing, Laura
    McClellan, Mark B.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (01) : 150 - 154
  • [37] Identification of pregnancies and pregnancy outcomes using real-world healthcare data
    Weil, Clara
    Rotem, Ran
    Sinha, Anushua
    Chodick, Gabriel
    Wang, Wei
    Calhoun, Shawna
    Bilavsky, Efraim
    Marks, Morgan A.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 529 - 530
  • [38] Safety of infliximab use during pregnancy
    Djokanovic, Nada
    Klieger-Grossmann, Chagit
    Pupco, Anna
    Koren, Gideon
    [J]. REPRODUCTIVE TOXICOLOGY, 2011, 32 (01) : 93 - 97
  • [39] INFLIXIMAB USE DURING PREGNANCY REVISITED
    Akinci, Aysen
    Ozcakar, Levent
    [J]. ACTA REUMATOLOGICA PORTUGUESA, 2008, 33 (03): : 374 - 375
  • [40] Inaccurate Real-World Data Does Not Provide Real-World Answers
    Buffet, Gabriela
    Mendoza-Sassi, Raul
    Fysekidis, Marinos
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (05) : E596 - E598
12345